Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan
To identify those who might benefit from weight reduction within a large population of obese individuals, Japan Society for the Study of Obesity (JASSO) advocated the concept of “obesity disease.” Here we summarize the definition, criteria, and core concepts for the management of obesity disease bas...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Japan Endocrine Society
2024-03-01
|
| Series: | Endocrine Journal |
| Subjects: | |
| Online Access: | https://www.jstage.jst.go.jp/article/endocrj/71/3/71_EJ23-0593/_html/-char/en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591727177760768 |
|---|---|
| author | Wataru Ogawa Yushi Hirota Shigeru Miyazaki Tadashi Nakamura Yoshihiro Ogawa Iichiro Shimomura Toshimasa Yamauchi Koutaro Yokote on behalf of the Creation Committee for Guidelines for the Management of Obesity Disease 2022 by Japan Society for the Study of Obesity (JASSO) |
| author_facet | Wataru Ogawa Yushi Hirota Shigeru Miyazaki Tadashi Nakamura Yoshihiro Ogawa Iichiro Shimomura Toshimasa Yamauchi Koutaro Yokote on behalf of the Creation Committee for Guidelines for the Management of Obesity Disease 2022 by Japan Society for the Study of Obesity (JASSO) |
| author_sort | Wataru Ogawa |
| collection | DOAJ |
| description | To identify those who might benefit from weight reduction within a large population of obese individuals, Japan Society for the Study of Obesity (JASSO) advocated the concept of “obesity disease.” Here we summarize the definition, criteria, and core concepts for the management of obesity disease based on JASSO’s latest guideline. JASSO defines obesity as excessive fat storage in adipose tissue associated with a BMI of ≥25 kg/m2. The threshold BMI of obesity is low as compared to Western countries given that Japanese individuals tend to develop obesity-related health disorders at lower BMI. Obesity with a BMI of ≥35 kg/m2 is referred to as “high-degree obesity” as treatment strategies vary based on the degree of obesity. Obesity is diagnosed as “obesity disease” if accompanied by any of the 11 specific obesity-related health disorders that weight reduction can prevent or alleviate, or if it meets the criteria for visceral fat obesity with a visceral fat area of ≥100 cm2. The initial weight reduction goals for high-degree obesity disease range from 5% to 10% of their current body weight, depending on the associated health disorders. That for those with obesity disease who do not qualify as high-degree is 3% or more. If these initial goals are not achieved, intensifying dietary therapy or introducing drug therapy (or both) may be necessary. While surgical treatment is primarily indicated for high-degree obesity disease, it might be appropriate for cases of obesity disease with a BMI <35 kg/m2, depending on the accompanying health disorders. Enhancing the quality of life for individuals with obesity or obesity disease necessitates a broader societal approach, emphasizing the resolution of related stigma. |
| format | Article |
| id | doaj-art-bc07feec861241f3863052cdbc3c8874 |
| institution | Kabale University |
| issn | 1348-4540 |
| language | English |
| publishDate | 2024-03-01 |
| publisher | The Japan Endocrine Society |
| record_format | Article |
| series | Endocrine Journal |
| spelling | doaj-art-bc07feec861241f3863052cdbc3c88742025-01-22T06:35:05ZengThe Japan Endocrine SocietyEndocrine Journal1348-45402024-03-0171322323110.1507/endocrj.EJ23-0593endocrjDefinition, criteria, and core concepts of guidelines for the management of obesity disease in JapanWataru Ogawa0Yushi Hirota1Shigeru Miyazaki2Tadashi Nakamura3Yoshihiro Ogawa4Iichiro Shimomura5Toshimasa Yamauchi6Koutaro Yokote7on behalf of the Creation Committee for Guidelines for the Management of Obesity Disease 2022 by Japan Society for the Study of Obesity (JASSO)Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanCenter for Comprehensive Health Check and Promotion, Japan Anti-Tuberculosis Association, Tokyo 101-8372, JapanDepartment of Internal Medicine, Kawasaki Hospital, Kobe 652-0042, JapanDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, JapanDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, JapanDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, JapanDepartment of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba 260-8670, JapanTo identify those who might benefit from weight reduction within a large population of obese individuals, Japan Society for the Study of Obesity (JASSO) advocated the concept of “obesity disease.” Here we summarize the definition, criteria, and core concepts for the management of obesity disease based on JASSO’s latest guideline. JASSO defines obesity as excessive fat storage in adipose tissue associated with a BMI of ≥25 kg/m2. The threshold BMI of obesity is low as compared to Western countries given that Japanese individuals tend to develop obesity-related health disorders at lower BMI. Obesity with a BMI of ≥35 kg/m2 is referred to as “high-degree obesity” as treatment strategies vary based on the degree of obesity. Obesity is diagnosed as “obesity disease” if accompanied by any of the 11 specific obesity-related health disorders that weight reduction can prevent or alleviate, or if it meets the criteria for visceral fat obesity with a visceral fat area of ≥100 cm2. The initial weight reduction goals for high-degree obesity disease range from 5% to 10% of their current body weight, depending on the associated health disorders. That for those with obesity disease who do not qualify as high-degree is 3% or more. If these initial goals are not achieved, intensifying dietary therapy or introducing drug therapy (or both) may be necessary. While surgical treatment is primarily indicated for high-degree obesity disease, it might be appropriate for cases of obesity disease with a BMI <35 kg/m2, depending on the accompanying health disorders. Enhancing the quality of life for individuals with obesity or obesity disease necessitates a broader societal approach, emphasizing the resolution of related stigma.https://www.jstage.jst.go.jp/article/endocrj/71/3/71_EJ23-0593/_html/-char/enobesityobesity diseasemanagement guidelinevisceral fat obesity |
| spellingShingle | Wataru Ogawa Yushi Hirota Shigeru Miyazaki Tadashi Nakamura Yoshihiro Ogawa Iichiro Shimomura Toshimasa Yamauchi Koutaro Yokote on behalf of the Creation Committee for Guidelines for the Management of Obesity Disease 2022 by Japan Society for the Study of Obesity (JASSO) Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan Endocrine Journal obesity obesity disease management guideline visceral fat obesity |
| title | Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan |
| title_full | Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan |
| title_fullStr | Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan |
| title_full_unstemmed | Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan |
| title_short | Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan |
| title_sort | definition criteria and core concepts of guidelines for the management of obesity disease in japan |
| topic | obesity obesity disease management guideline visceral fat obesity |
| url | https://www.jstage.jst.go.jp/article/endocrj/71/3/71_EJ23-0593/_html/-char/en |
| work_keys_str_mv | AT wataruogawa definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan AT yushihirota definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan AT shigerumiyazaki definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan AT tadashinakamura definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan AT yoshihiroogawa definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan AT iichiroshimomura definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan AT toshimasayamauchi definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan AT koutaroyokote definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan AT onbehalfofthecreationcommitteeforguidelinesforthemanagementofobesitydisease2022byjapansocietyforthestudyofobesityjasso definitioncriteriaandcoreconceptsofguidelinesforthemanagementofobesitydiseaseinjapan |